MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Motoneuron disease"

  • 2016 International Congress

    Frontal lobe white matter atrophy correlates with disability in spastic paraplegia type 11 (SPG11)

    I. Faber, A.R.M. Martinez, T.T.J. Rezende, R.F. Casseb, C.M. Lourenço, W. Marques Jr, J.L. Pedroso, O.G.P. Barsottini, I.T. Lopes-Cendes, M.C. França Jr (Campinas, Brazil)

    Objective: To evaluate in vivo signs of gray matter (GM) and white matter (WM) abnormalities, through an unbiased neuroimaging method, in a large cohort of…
  • 2016 International Congress

    Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases

    H. Schmitz-Peiffer, K. Linse, W. Rüger, M. Joos, M. Löhle, A. Storch, A. Hermann (Dresden, Germany)

    Objective: To develop and evaluate motor-free procedures via eye tracking for determining cognitive functions in patients with idiopathic Parkinson's disease (PD) and motor neuron disease…
  • 2016 International Congress

    ECG-based cardiopulmonary coupling for sleep stability assessment in patients with amyotrophic lateral sclerosis

    S. Mariani, P. Congiu, G. Milioli, G. Gioi, G. Borghero, F. Marrosu, R.J. Thomas, A.L. Goldberger, M. Puligheddu (Boston, MA, USA)

    Objective: The goal of this preliminary study is to introduce the technique of CardioPulmonary Coupling (CPC) to visualize and quantify the sleep spectrograms of Amyotrophic…
  • 2016 International Congress

    A rapid chemical-genetic screen utilising impaired movement phenotypes in caenorhabditis elegans

    K. Schmeisser, Y.F. Ghassemi, C. Maios, A. Parker (Montreal, QC, Canada)

    Objective: Development of a fast and unbiased screening method to identify C. elegans mutants with movement disabilities and drugs to improve impaired locomotion. Background: Identifying…
  • « Previous Page
  • 1
  • 2

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley